A simple and reliable method is described here to analyze a set of NK cell functions such as degranulation, cytokine and chemokine production within different NK cell subsets.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
A simple and reliable method is described here to analyze a set of NK cell functions such as degranulation, cytokine and chemokine production within different NK cell subsets.
Natural killer (NK) cells are an important part of the human tumor immune surveillance system. NK cells are able to distinguish between healthy and virus-infected or malignantly transformed cells due to a set of germline encoded inhibitory and activating receptors. Upon virus or tumor cell recognition a variety of different NK cell functions are initiated including cytotoxicity against the target cell as well as cytokine and chemokine production leading to the activation of other immune cells. It has been demonstrated that accurate NK cell functions are crucial for the treatment outcome of different virus infections and malignant diseases. Here a simple and reliable method is described to analyze different NK cell functions using a flow cytometry-based assay. NK cell functions can be evaluated not only for the whole NK cell population, but also for different NK cell subsets. This technique enables scientists to easily study NK cell functions in healthy donors or patients in order to reveal their impact on different malignancies and to further discover new therapeutic strategies.
As part of the innate immune system natural killer (NK) cells contribute to the first line of defense against virus-infected or malignantly transformed cells. A system of inhibitory and activating receptors enables them to distinguish between healthy and transformed cells without prior antigen priming in contrast to T cells. Upon target cell encounter NK cells release the content of their cytotoxic granules (e.g., perforin, granzymes) into the immune synapse to kill their target. Moreover, NK cells produce and secrete different kinds of cytokines (e.g., interferon- γ: IFN-γ; tumor necrosis factor-α: TNF-α) and chemokines ....
Access restricted. Please log in or start a trial to view this content.
This study was carried out in accordance with the recommendations of the local ethics committee of the University of Frankfurt.
1. Culturing of K562 Cells
Access restricted. Please log in or start a trial to view this content.
The gating strategy for analyzing the degranulation, cytokine and chemokine production of the whole NK cell population and three different NK cell subsets are illustrated in Figure 1.
Representative results of one healthy donor are illustrated in Figure 2. NK cells without any stimulus produced neither IFN-γ nor MIP-1β and did not express CD107a on their surface (Figure 2A). In .......
Access restricted. Please log in or start a trial to view this content.
The described method is an easy, fast and reliable approach to study NK cell functions from whole blood samples of healthy donors or patients. This method offers the great advantage to directly purify NK cells from whole blood, avoiding the time-consuming density gradient centrifugation, which is mandatory for many other purification methods15. Moreover, it requires a smaller sample size compared to "classical" NK cell isolation/enrichment methods, which makes it a suitable alternative for samples of p.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
Authors were supported by the German Cancer Aid (Max Eder Nachwuchsgruppe, Deutsche Krebshilfe; EU), the LOEWE Center for Cell and Gene Therapy Frankfurt (EU, ST) funded by the Hessian Ministry of Higher Education, Research and the Arts, Germany (III L 4- 518/17.004) and by the "Alfred- und Angelika Gutermuth-Stiftung", Frankfurt, Germany (EU). BJ was funded by a Mildred Scheel postdoctoral scholarship from the Dr. Mildred Scheel Foundation for Cancer Research. ST was founded by a GO-IN postdoctoral fellowship (PCOFUND-GA-2011-291776). The authors thank Becton Dickinson (BD) for providing the FACSCanto II and Canto10c Flow Cytometry Analyzers used in this study.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| RPMI 1640 + glutamine | Invitrogen | 6187-044 | |
| penicilin/streptomycin | Invitrogen | 15140-122 | |
| BD Falcon Round Bottom Tube | BD | 352008 | |
| fetal calf serum | Invitrogen | 10270-106 | heat inactivated before use |
| T-flask | Greiner Bio-One | 690195 | |
| K562 tumor cell line | DSMZ GmbH | ACC 10 | |
| ammonium-chloride-potassium (ACK) lysis buffer | made in house | / | components are listed in the text |
| Distilled water: Ampuwa Spüllösung 1,000 ml Plastipur | Fresenius Kabi | 1088813 | |
| Megafuge 40R Centrifuge | Heraeus | / | |
| EDTA blood collector tubes | Sarstedt | 386453 | S-Monovette 7.5 ml, K3EDTA |
| UltraPure 0.5 M EDTA, pH 8.0 | Life Technologies | 15575-020 | |
| Hematopoietic media (XVIVO) | Lonza Group Ltd | BE04-743Q | |
| human serum | DRK Blutspendedienst, Frankfurt/M | / | healthy donors with blood type AB; heat inactivated before use |
| Neubauer-improved counting chamber, bright line | Marienfeld superior/ LO-Laboroptik Ltd. | 0640030/ 1110000 | |
| trypan blue solution (0.4%) | Invitrogen | 15250-061 | |
| 3% acetic acid with methylene blue | Stemcell Technologies | 07060 | |
| Corning 96 Well Clear V-Bottom TC-treated Microplates | Corning | 3894 | |
| Falcon 96 Well Round Bottom Not Treated Microplates | Corning | 351177 | |
| DPBS (Ca2+- and Mg2+-free) | Gibco Invitrogen | 14190-169 | |
| BSA | Sigma Aldrich | A2153-100G | |
| NaN3 | Sigma Aldrich | 08591-1ML-F | |
| phorbol 12-myristate 13-acetate (PMA) | Merck | 524400-1MG | |
| ionomycin | PromoKine | PK-CA577-1566-5 | |
| interleukin 15 (IL-15) | PeproTech | 200-15 | |
| Proleukin S (IL-2) | Novartis Pharma | 730523 | |
| Golgi Stop, Protein Transport Inhibitor (containing Monensin) | BD Biosciences | 554724 | This product can be used in combination or instead of Golgi Plug. The best combination for the wished experimental setting has to be tested. |
| Golgi Plug, Protein Transport Inhibitor (containing Brefeldin A) | BD Biosciences | 555029 | |
| paraformaldehyde | AppliChem | UN2209 | |
| saponin | Sigma Aldrich | 47036 | |
| flow cytometer: Canto10C | BD Biosciences | / | |
| FlowJo | TreeStar Inc. | / | |
| Graph Pad | Graph Pad Inc. | / | |
| MACSxpress Separator | Miltenyi Biotec | 130-098-308 | |
| MACSxpress NK isolation kit | Miltenyi Biotec | 130-098-185 | |
| MACSxpress Erythrocyte Depletion Kit, human | Miltenyi Biotec | 130-098-196 | |
| MACSmix Tube Rotator | Miltenyi Biotec | 130-090-753 | |
| anti-human CD3 APC | Biolegend | 300412 | |
| anti-human CD3 V450 | BD Biosciences | 560366 | |
| anti-human CD14 PerCP | Miltenyi Biotec | 130-094-969 | |
| anti-human CD14 V450 | BD Biosciences | 560349 | |
| anti-human CD16 PE | Biolegend | 302008 | |
| anti-human CD16 PerCP | Biolegend | 302029 | |
| anti-human CD19 PE-Cy7 | Biolegend | 302216 | |
| anti-human CD19 V450 | BD Biosciences | 560353 | |
| anti-human CD45 BV510 | BD Biosciences | 563204 | |
| anti-human CD56 FITC | Biolegend | 345811 | |
| anti-human CD107a PE | Biolegend | 328608 | |
| anti-human IFN-γ AF-647 | BD Biosciences | 557729 | |
| anti-human MIP-1β APC-H7 | BD Biosciences | 561280 | |
| DAPI | Biolegend | 422801 | |
| Zombie Violet Fixable Viability Kit | Biolegend | 423113 | fixable dead cell marker |
Access restricted. Please log in or start a trial to view this content.